EFB Newsletter - July 2026
Wednesday, 29 July 2026 02:10
ASBE8: extended deadlines and early career scientist bursaries The deadlines for abstract submission and early bird registration for the Applied Synthetic Biology in Europe (ASBE Conference) have been extended to 16 August 2026. Submit your abstract and register before the deadline to benefit from the reduced registration fee. In addition, we offer early career bursaries supported by the Federation of European Microbiological Societies (FEMS) and the EFB Bioengineering and Bioprocessing Division and the EFB Microbial Biotechnology Division. Bursary application deadline: 16 August 2026 ASBE8 will take place on 4–6 November 2026 in Manchester, UK. Registration Thank you for making ECB2026 a success As ECB2026 comes to a close, we would like to thank everyone who contributed to its success. We are grateful to all delegates, speakers, session chairs and exhibitors for making the Congress a meeting point for the biotechnology community, with participants from every continent. Our…
Published in
Mitgliedsnews
Your FEBS Network highlights - Mid July
Monday, 27 July 2026 09:01
Hello dear ÖGMBT members, Here's a list of the great content selected as a highlight in the past 2 weeks. New course on advanced lipidomics technologies We are delighted to announce an exciting new hands-on course on advanced lipidomics: the FEBS Combined Practical and Lecture Course ‘Advanced lipidomics technologies to study lipid biology’. It wil... Read more Maria Fedorova Professor for Lipidome Research, Technical University Dresden Could your research be the next FEBS Excellence Award? Building an independent research career takes ambition, resilience and the right opportunities. If you're ready to take the next step, the 2026 FEBS Excellence Awards could help turn your next rese... Read more FEBS Communications IUBMB Focused Meeting on Synthetic Biology 2027: Abstract submissions now open Join researchers from around the world at the IUBMB Focused Meeting on Synthetic Biology, taking place in Bengaluru, India, on 15–17 February 2027. Submit your abstract…
Published in
Mitgliedsnews
GenScript Launches TurboCHO™ Protein Expression Kit, Delivering the Fastest Path to Antibodies
Tuesday, 02 June 2026 02:26
GenScript Launches TurboCHO™ Protein Expression Kit, Delivering the Fastest Path to Antibodies in its Class New kit offers researchers and development teams a meaningful advance in expression speed and output May 12, 2026 BOSTON, May 12, 2026 /PRNewswire/ -- GenScript Biotech Corporation announced the launch of TurboCHO™ Protein Expression Kit, a next-generation antibody expression reagent designed to set a new benchmark for speed, performance, output and ease-of-use. One of the company's largest global product launches to date, this kit targets the fast-growing expression reagent market, driven by high-throughput and AI-enabled research. Introducing the TurboCHO™ Protein Expression Kit, a launchpad in every kit. Producing research-grade antibodies and proteins is a foundational step in drug discovery and biologics development. The new kit brings GenScript's proven protein-expression technology directly to the bench in a ready-to-use format, enabling labs of any size to generate high‑quality protein in as little as five business days. As a result, researchers can access reliable…
Published in
Mitgliedsnews
